Bayer Revenue 2006-2021 | BAYRY

Bayer revenue from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bayer Annual Revenue
(Millions of US $)
2020 $47,291
2019 $48,770
2018 $46,751
2017 $39,577
2016 $51,755
2015 $51,438
2014 $56,148
2013 $53,341
2012 $51,135
2011 $50,876
2010 $46,593
2009 $43,467
2008 $48,432
2007 $44,390
2006 $36,375
2005 $34,103
Bayer Quarterly Revenue
(Millions of US $)
2021-03-31 $14,863
2020-12-31 $12,107
2020-09-30 $9,944
2020-06-30 $11,070
2020-03-31 $14,171
2019-12-31 $10,148
2019-09-30 $10,931
2019-06-30 $12,909
2019-03-31 $14,782
2018-12-31 $12,695
2018-09-30 $11,517
2018-06-30 $11,307
2018-03-31 $11,232
2017-12-31 $4,102
2017-09-30 $9,432
2017-06-30 $13,411
2017-03-31 $12,633
2016-12-31 $12,646
2016-09-30 $12,568
2016-06-30 $13,367
2016-03-31 $13,173
2015-12-31 $12,109
2015-09-30 $12,279
2015-06-30 $13,374
2015-03-31 $13,676
2014-12-31 $13,819
2014-09-30 $13,517
2014-06-30 $14,346
2014-03-31 $14,466
2013-12-31 $13,477
2013-09-30 $12,774
2013-06-30 $13,529
2013-03-31 $13,560
2012-12-31 $12,779
2012-09-30 $12,095
2012-06-30 $13,078
2012-03-31 $13,183
2011-12-31 $12,366
2011-09-30 $12,277
2011-06-30 $13,314
2011-03-31 $12,870
2010-12-31 $12,390
2010-09-30 $11,069
2010-06-30 $11,712
2010-03-31 $10,969
2009-12-31 $11,282
2009-09-30 $11,087
2009-06-30 $10,908
2009-03-31 $10,327
2008-12-31 $10,151
2008-09-30 $11,978
2008-06-30 $13,303
2008-03-31 $12,787
2007-12-31 $11,680
2007-09-30 $10,708
2007-06-30 $11,077
2007-03-31 $10,919
2006-12-31 $8,552
2006-09-30 $9,931
2006-06-30 $8,882
2006-03-31 $8,170
2005-12-31 $8,442
2005-09-30 $7,968
2005-06-30 $8,894
2005-03-31 $8,600
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $0.000B $47.287B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $435.090B 19.86
Roche Holding AG (RHHBY) Switzerland $325.235B 0.00
Pfizer (PFE) United States $220.997B 13.85
Novartis AG (NVS) Switzerland $215.481B 16.43
Eli Lilly (LLY) United States $213.105B 27.60
AbbVie (ABBV) United States $202.939B 10.41
Merck (MRK) United States $195.551B 13.25
Novo Nordisk (NVO) Denmark $194.907B 28.74
AstraZeneca (AZN) United Kingdom $153.145B 25.37
Sanofi (SNY) $134.055B 15.57
GlaxoSmithKline (GSK) United Kingdom $109.239B 15.31
H Lundbeck (HLUYY) Denmark $6.108B 10.50
Innoviva (INVA) United States $1.314B 5.25